“To make clinical and biological observations in a time-frame likely to benefit patients during disease outbreaks, coordination in global research must match the speed of spread of novel pathogens. Time is short. Circumstances compel us to work together, across the world, to understand, treat, and prevent COVID-19.“
This article aims to highlight how harmonisation of clinical investigation during outbreaks can be beneficial by facilitating data share, collaborative studies, peer review of shared protocols and compare results.
“Wide collaboration leads to better, faster science.“
- Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19
- What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? - A harmonised, global longitudinal observational study
- An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus streptomycin + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a rando